Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000356268 | SCV000341772 | likely benign | not specified | 2016-05-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000878654 | SCV001021591 | benign | Congenital primary aphakia; Anterior segment dysgenesis | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001651321 | SCV001867922 | benign | not provided | 2020-10-27 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 20140963) |
Ambry Genetics | RCV002401998 | SCV002712460 | likely benign | Cardiovascular phenotype | 2019-03-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001651321 | SCV005260387 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000356268 | SCV001977881 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000356268 | SCV001979010 | benign | not specified | no assertion criteria provided | clinical testing |